AMPH: Bullish move ahead

NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Technical Analysis:
OBV - uptrend
Heiken Ashi - Bullish signal

Expectation to the first point of resistance (Target 1)
Potential for continuation once resistance is broken.

Take profits would be set below the resistance level at 20, and stop-loss at just below the upward trend of 18.80.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.